The Allstate Co. (NYSE:ALL) Shares Acquired by Invesco LLC

Invesco LLC raised its holdings in The Allstate Co. (NYSE:ALL) by 1.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,040 shares of the insurance provider’s stock after acquiring an additional 167 shares during the quarter. Allstate accounts for about 1.1% of Invesco LLC’s portfolio, making the stock its 24th biggest holding. Invesco LLC’s holdings in Allstate were worth $2,663,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of ALL. Northwest Investment Counselors LLC acquired a new stake in Allstate in the 3rd quarter valued at about $28,000. Versant Capital Management Inc lifted its holdings in Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 78 shares during the last quarter. Family Firm Inc. acquired a new stake in Allstate in the 2nd quarter valued at about $38,000. MCF Advisors LLC lifted its holdings in Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after acquiring an additional 84 shares during the last quarter. Finally, First Command Advisory Services Inc. acquired a new stake in Allstate in the 2nd quarter valued at about $58,000. 76.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the transaction, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at $15,880,915.68. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares of the company’s stock, valued at $3,431,901.67. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock valued at $34,967,665 over the last ninety days. 1.80% of the stock is owned by company insiders.

Analyst Ratings Changes

ALL has been the subject of a number of research analyst reports. Bank of America upped their price target on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a report on Friday, October 18th. Roth Mkm reaffirmed a “buy” rating and set a $200.00 price objective on shares of Allstate in a research note on Wednesday, August 14th. UBS Group upped their price objective on shares of Allstate from $215.00 to $216.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. TD Cowen upped their price objective on shares of Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. Finally, Barclays upped their price objective on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research note on Thursday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $207.19.

Allstate Stock Performance

Shares of ALL traded down $2.37 during mid-day trading on Friday, hitting $184.15. The company’s stock had a trading volume of 1,533,736 shares, compared to its average volume of 1,546,804. The Allstate Co. has a one year low of $127.93 and a one year high of $198.79. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36. The firm has a market capitalization of $48.62 billion, a PE ratio of 11.93, a price-to-earnings-growth ratio of 1.91 and a beta of 0.48. The stock’s 50-day moving average is $188.87 and its two-hundred day moving average is $175.16.

Allstate (NYSE:ALL) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a return on equity of 27.74% and a net margin of 6.77%. Allstate’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.81 earnings per share. As a group, sell-side analysts anticipate that The Allstate Co. will post 14.16 EPS for the current year.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.